Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Orsini

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Investigation|August 6, 1998
Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12J A Gollob, C P Schnipper, E Orsini, et al.
Leukemia|July 28, 2016
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignanciesC Evangelisti, C Evangelisti, F Buontempo, et al.
Leukemia|September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemiasF Buontempo, J A McCubrey, E Orsini, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Clinical Investigation|August 6, 1998
Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12J A Gollob, C P Schnipper, E Orsini, et al.
Leukemia|July 28, 2016
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignanciesC Evangelisti, C Evangelisti, F Buontempo, et al.
Leukemia|September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemiasF Buontempo, J A McCubrey, E Orsini, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Pageof 5